HCA Healthcare Inc (NYSE:HCA) SVP J William Morrow sold 263 shares of HCA Healthcare stock in a transaction that occurred on Thursday, February 7th. The shares were sold at an average price of $140.60, for a total transaction of $36,977.80. Following the completion of the sale, the senior vice president now owns 5,922 shares of the company’s stock, valued at approximately $832,633.20. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Shares of HCA stock traded down $0.87 on Monday, reaching $138.66. 1,008,119 shares of the stock were exchanged, compared to its average volume of 1,587,261. The company has a market cap of $48.02 billion, a P/E ratio of 14.19, a PEG ratio of 1.16 and a beta of 0.80. HCA Healthcare Inc has a twelve month low of $93.03 and a twelve month high of $147.42.
HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 29th. The company reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.59 by $0.40. The firm had revenue of $12.27 billion during the quarter, compared to the consensus estimate of $12.10 billion. HCA Healthcare had a net margin of 8.11% and a negative return on equity of 91.25%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.12 earnings per share. As a group, equities analysts expect that HCA Healthcare Inc will post 10.02 earnings per share for the current fiscal year.
Several hedge funds have recently modified their holdings of the stock. Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the fourth quarter valued at $25,000. Moody National Bank Trust Division purchased a new stake in HCA Healthcare in the fourth quarter valued at $27,000. Doyle Wealth Management purchased a new stake in HCA Healthcare in the fourth quarter valued at $31,000. Trust Co. of Vermont lifted its position in HCA Healthcare by 165.3% in the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock valued at $41,000 after acquiring an additional 205 shares during the last quarter. Finally, Csenge Advisory Group purchased a new stake in HCA Healthcare in the third quarter valued at $48,000. Hedge funds and other institutional investors own 72.85% of the company’s stock.
HCA has been the subject of several research reports. Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $157.00 target price for the company in a report on Monday, November 19th. Deutsche Bank started coverage on shares of HCA Healthcare in a research note on Thursday, January 3rd. They issued a “buy” rating and a $140.00 price target for the company. Oppenheimer boosted their price target on shares of HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. UBS Group started coverage on shares of HCA Healthcare in a research note on Thursday, November 15th. They issued a “buy” rating and a $162.00 price target for the company. Finally, Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $155.00 to $158.00 and gave the stock a “buy” rating in a research note on Wednesday, October 31st. Two analysts have rated the stock with a sell rating, two have given a hold rating and eighteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $148.43.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: How is the LIBOR rate calculated?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.